Screening  	Screening  	 VBG	O
for  	for  	 IN	O
BRCA1  	BRCA1  	 NNP	B-NP
and  	and  	 CC	O
BRCA2  	BRCA2  	 CD	B-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
breast  	breast  	 JJ	O
cancer  	cancer  	 NN	O
patients  	patients  	 NNS	O
from  	from  	 IN	O
Mexico 	Mexico 	 NNP	B-NP
:  	:  	 :	O
the  	the  	 DT	O
public  	public  	 JJ	B-NP
health  	health  	 NN	I-NP
perspective  	perspective  	 NN	I-NP
Genetic  	Genetic  	 JJ	I-NP
testing  	testing  	 NN	I-NP
for  	for  	 IN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
BRCA1  	BRCA1  	 NNP	B-NP
and  	and  	 CC	O
BRCA2  	BRCA2  	 NNP	B-NP
has  	has  	 VBZ	O
potentially  	potentially  	 RB	O
important  	important  	 JJ	O
public  	public  	 JJ	B-NP
health  	health  	 NN	I-NP
implications 	implications 	 NNS	I-NP
.  	.  	 .	O
Through  	Through  	 IN	O
judicious  	judicious  	 JJ	B-NP
testing  	testing  	 NN	I-NP
of  	of  	 IN	O
women  	women  	 NNS	O
believed  	believed  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
at  	at  	 IN	O
high  	high  	 JJ	O
risk  	risk  	 NN	O
for  	for  	 IN	O
early-onset  	early-onset  	 JJ	B-NP
breast  	breast  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
and  	and  	 CC	O
for  	for  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
possible  	possible  	 JJ	O
to  	to  	 TO	O
identify  	identify  	 VB	O
highly-predisposed  	highly-predisposed  	 JJ	O
women  	women  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
Current  	Current  	 JJ	B-NP
preventive  	preventive  	 JJ	I-NP
options  	options  	 NNS	I-NP
include  	include  	 VBP	O
preventive  	preventive  	 JJ	B-NP
mastectomy 	mastectomy 	 NN	I-NP
,  	,  	 ,	O
preventive  	preventive  	 JJ	B-NP
oophorectomy 	oophorectomy 	 NN	I-NP
,  	,  	 ,	O
tamoxifen  	tamoxifen  	 NN	B-NP
and  	and  	 CC	O
oral  	oral  	 JJ	B-NP
contraceptives 	contraceptives 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
offer  	offer  	 VB	O
genetic  	genetic  	 JJ	B-NP
testing  	testing  	 NN	I-NP
in  	in  	 IN	O
Mexico  	Mexico  	 NNP	B-NP
on  	on  	 IN	O
a  	a  	 DT	O
widespread  	widespread  	 JJ	O
level  	level  	 NN	O
is  	is  	 VBZ	O
enhanced  	enhanced  	 VBN	O
if  	if  	 IN	O
the  	the  	 DT	O
common  	common  	 JJ	O
founder  	founder  	 NN	B-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
genes  	genes  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
discovered  	discovered  	 VBN	O
or  	or  	 CC	O
if  	if  	 IN	O
the  	the  	 DT	O
cost  	cost  	 NN	O
of  	of  	 IN	O
genetic  	genetic  	 JJ	B-NP
sequencing  	sequencing  	 NN	I-NP
is  	is  	 VBZ	O
reduced 	reduced 	 VBN	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
important  	important  	 JJ	O
that  	that  	 IN	O
a  	a  	 DT	O
genetic  	genetic  	 JJ	B-NP
testing  	testing  	 NN	I-NP
service  	service  	 NN	I-NP
be  	be  	 VB	O
a  	a  	 DT	O
multi-disciplinary  	multi-disciplinary  	 JJ	B-NP
effort  	effort  	 NN	I-NP
with  	with  	 IN	O
co-ordinated  	co-ordinated  	 JJ	B-NP
follow-up 	follow-up 	 NN	I-NP
.  	.  	 .	O
